Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report.
Boongird S, Chuengsaman P, Phanprasert S, Kitpermkiat R, Assanatham M, Nongnuch A, Kiertiburanakul S, Malathum K, Phuphuakrat A, Setthaudom C, Bruminhent J. Boongird S, et al. Among authors: kitpermkiat r. Kidney Int. 2021 Nov;100(5):1136-1138. doi: 10.1016/j.kint.2021.08.007. Epub 2021 Aug 19. Kidney Int. 2021. PMID: 34419552 Free PMC article. No abstract available.
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.
Bruminhent J, Setthaudom C, Kitpermkiat R, Kiertiburanakul S, Malathum K, Assanatham M, Nongnuch A, Phuphuakrat A, Chaumdee P, Janphram C, Thotsiri S, Chuengsaman P, Boongird S. Bruminhent J, et al. Among authors: kitpermkiat r. Sci Rep. 2022 Mar 4;12(1):3587. doi: 10.1038/s41598-022-07574-w. Sci Rep. 2022. PMID: 35246578 Free PMC article.
Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine.
Boongird S, Chuengsaman P, Setthaudom C, Nongnuch A, Assanatham M, Phanprasert S, Kitpermkiat R, Kiertiburanakul S, Malathum K, Phuphuakrat A, Davenport A, Bruminhent J. Boongird S, et al. Among authors: kitpermkiat r. Infect Dis Ther. 2022 Feb;11(1):351-365. doi: 10.1007/s40121-021-00574-9. Epub 2021 Dec 3. Infect Dis Ther. 2022. PMID: 34859359 Free PMC article.
Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3).
Boongird S, Setthaudom C, Kitpermkiat R, Prasongtanakij S, Srisala S, Chuengsaman P, Nongnuch A, Assanatham M, Kiertiburanakul S, Malathum K, Phuphuakrat A, Bruminhent J. Boongird S, et al. Among authors: kitpermkiat r. Vaccines (Basel). 2022 Jul 1;10(7):1064. doi: 10.3390/vaccines10071064. Vaccines (Basel). 2022. PMID: 35891228 Free PMC article.
A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation.
Kitpermkiat R, Thotsiri S, Arpornsujaritkun N, Sangkum P, Chantrathammachart P, Kitpoka P, Thammanichanond D, Virankabutra T, Kantachuvesiri S. Kitpermkiat R, et al. Am J Case Rep. 2022 Jul 17;23:e935451. doi: 10.12659/AJCR.935451. Am J Case Rep. 2022. PMID: 35842751 Free PMC article.